US EditionPurdue Pharma Outlines Opioid Suit Settlement Plan That Includes Up To $7 Billion From Sackler Family
- Purdue Pharma proposed a bankruptcy plan to distribute more than $7.4 billion to creditors, including up to $7 billion from the Sackler family to aid victims of the opioid crisis.
- The Sackler family will pay around $6.5 billion in installments over 15 years, starting with an upfront $1.5 billion payment.
- The new plan offers direct cash assistance for victims of the opioid crisis, potentially totaling over $850 million for affected individuals and families.
- This settlement marks a significant commitment from Purdue Pharma, which will transfer ownership in exchange for financial compensation to support victim recovery.
42 Articles
42 Articles
Purdue Pharma submits opioid suit settlement, including up to $7 billion cash from Sacklers
Purdue Pharma asked a bankruptcy judge this week to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin, a deal that would have members of the Sackler family…
Purdue Pharma submits opioid lawsuit settlement plan, including up to $7B cash from Sacklers
Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin, a deal that would have members of the Sackler family who own the company pay up to $7 billion.
KLAS - 8 News Now
WGN 9OxyContin maker files new bankruptcy plan, including up to $7 billion from Sackler family
Purdue Pharma files new bankruptcy plan to settle opioid lawsuits. Sackler family to pay $1.5 billion on settlement date, with $6.5 billion over 15 years.
Coverage Details
Bias Distribution
- 54% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
